Similar articles

• Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia.

  Narang PK, Blumhardt CL, Doran AR, Pickar D. Narang PK, et al. Clin Pharmacol Ther. 1988 Nov;44(5):550-7. doi: 10.1038/clpt.1988.193. Clin Pharmacol Ther. 1988. PMID: 3180637
• [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].

  Woodcock BG, Wörner P, Rietbrock N, Schwabe L, Frömming KH. Woodcock BG, et al. Arzneimittelforschung. 1982;32(12):1567-71. Arzneimittelforschung. 1982. PMID: 6891597 German.
• Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.

  Krecic-Shepard ME, Barnas CR, Slimko J, Schwartz JB. Krecic-Shepard ME, et al. Clin Pharmacol Ther. 2000 Sep;68(3):286-92. doi: 10.1067/mcp.2000.109356. Clin Pharmacol Ther. 2000. PMID: 11014410 Clinical Trial.
• [A suicide attempt with oral verapamil: a case report].

  Rodríguez Blanco VM, Rodríguez Suárez ML, Möller Bustinza I, Castellanos Martínez E, Puebla Rojo V, Barriales Alvarez V, Cortina Llosa A. Rodríguez Blanco VM, et al. Rev Esp Cardiol. 1993 Dec;46(12):837-9. Rev Esp Cardiol. 1993. PMID: 8134697 Review. Spanish.
• [Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation].

  Petri H, Kafka W, Rudolph W. Petri H, et al. Herz. 1983 Jun;8(3):144-52. Herz. 1983. PMID: 6347850 Review. German. No abstract available.